Neoplasia/BPH

	Evaluation of the diagnostic value of three YiDiXie tests in prostate cancer: an observational prospective single-center study. Sci Rep Li X, Sun C, Lin S, Ge Z, Zhang P, Wang W, Chen S, Wu Y, Zhou H, Huang R, Ni L, Lai Y. PMID: 41965732 [PubMed - as supplied by publisher]
	Belzutifan Efficacy in Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma Versus Natural History Control Arm. J Natl Cancer Inst Linehan WM, Jemielita T, Cornell J, Chen K, Ball MW, Srinivasan R, Liu Y, Perini RF, Pinto CA. PMID: 41964905 [PubMed - as supplied by publisher]
	The prognostic value of the CALLY index in patients with metastatic hormone-sensitive prostate cancer. World J Urol Wei B, Chen G, Liu M, Gan S, Bai Z, Wang Z, Guo X, He J. PMID: 41964875 [PubMed - indexed for MEDLINE]
	Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates. Curr Urol Rep Angulo-Lozano JC, Calvillo-Ramirez A, Noyola-Perez A, Cojuc-Konigsberg G, Vaquera-Alfaro H, Anceno A, Suzman E, Sanchez-Musi LF, Ponce CFMS, Pichardo-Rojas P, Badin-Castro J, Abrahimi P, Scherr DS. PMID: 41964855 [PubMed - in process]
	Comparison of biopsy gleason pattern 4 percentage and length in grade group 2 prostate cancer patients. Virchows Arch Belisario YMG, Hollemans E, van Leenders GJLH. PMID: 41964720 [PubMed - as supplied by publisher]
	Mechanistic Insights Into the Anti-Benign Prostatic Hyperplasia Effect of Licorice Water Extract via p53-Mediated Apoptosis and Cell Cycle Arrest: A Network Pharmacology-Based Experimental Study. Mol Nutr Food Res Kim HJ, Jin BR, Park SH, Kang SH, Jin JS, Kim DG, An HJ. PMID: 41964254 [PubMed - indexed for MEDLINE]
	Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study). Int J Urol Muta R, Fukushima H, Tanaka H, Numao N, Nakamura Y, Yoshinaga A, Kawamura N, Yonese I, Izumi K, Yamamoto T, Uehara S, Suzuki K, Toide M, Takazawa R, Araki S, Yoshida S, Fujii Y. PMID: 41964179 [PubMed - indexed for MEDLINE]
	Mitophagy in bladder cancer: a double-edged sword in tumor progression and therapy. J Transl Med Chen Q, Chen T, Gan L, Lu Y, Qian B. PMID: 41963956 [PubMed - as supplied by publisher]
	Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications. Clin Transl Oncol Willisch P, Vázquez-Barreiro B, Plata A, Belmonte IC, Guardia G, Del Castillo-Acuña R, Francolini G, Franzese C, Henríquez JDS, Couñago F, López-Campos F. PMID: 41963635 [PubMed - as supplied by publisher]
	Latin American Consensus for the Diagnosis and Treatment of Metastatic Castration-Sensitive Prostate Cancer. Clin Genitourin Cancer Losco F, Villareal Trujillo N, Jardim DL, Rodríguez-Covarrubias F, Perichón S, Bourlon MT, Martins da Trindade K, Villoldo G, Neciosup S, Sánchez H, Dominguez J, Ibatá L, Martínez-Rojas S, Kopp RM. PMID: 41963237 [PubMed - as supplied by publisher]
	Correlation between histologic features and Decipher genomic risk in prostate cancer biopsies. Ann Diagn Pathol Takeda K. PMID: 41962405 [PubMed - as supplied by publisher]
	Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385]. Radiother Oncol Sittiwong W, Lydon A, Wylie J, Ahmed I, Challapalli A, Hoskin P. PMID: 41962333 [PubMed - as supplied by publisher]
	Transformer-Enhanced Joint Information Extraction Framework for Bladder Cancer Medical Dialogue Analysis. IEEE J Biomed Health Inform Song Y, Yang Y, Qin J, Zhang Q. PMID: 41961567 [PubMed - as supplied by publisher]
	Evaluating an AI-driven Triaging Workflow for MRI-based Clinically Significant Prostate Cancer Diagnosis: A Simulation Study. Radiol Imaging Cancer Twilt JJ, Saha A, Bosma JS, Giannarini G, Padhani AR, Yakar D, Elschot M, Veltman J, Fütterer J, Huisman H, de Rooij M, PI-CAI Consortium. PMID: 41960994 [PubMed - indexed for MEDLINE]
	Biomaterial-Driven Integrated Therapy for Renal Cell Carcinoma: Renal Cancer Control and Kidney Injury Repair. Research (Wash D C) Song J, Zhang T, Li M, Liu W, Chen T, Qiang H, Wang L, Wu Z, Gao J. PMID: 41960572 [PubMed]
	Use of Single-Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma. Hum Mutat Yi X, Jia Z, Wu J, Wang S, Yu Y, Kong Y, He X, Huang Y. PMID: 41960370 [PubMed - indexed for MEDLINE]
	Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear accelerator. Phys Imaging Radiat Oncol Serpa M, Wiehle R, Rothe T, Küchler S, Fechter T, Sachpazidis I, Rizzo C, Adebahr S, Kuhn S, Toncheva P, Baltas D, Zamboglou C, Grosu AL, Spohn SKB. PMID: 41958959 [PubMed]
	Clinical management of cancer after kidney transplantation. Front Immunol Hiramitsu T, Ienaga A, Shimamoto Y, Himeno T, Hasegawa Y, Futamura K, Okada M, Narumi S, Watarai Y. PMID: 41958670 [PubMed - indexed for MEDLINE]
	The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis. Front Immunol Lyu Z, Xiao Y, Wang J, Wu R, Yoo KH, Wei W, Zhang Q, Xie Y, Feng D. PMID: 41958645 [PubMed - indexed for MEDLINE]
	Efficacy of androgen deprivation therapy (ADT) in combination with radiation therapy, compared to ADT alone in patients with high-risk prostate cancer: an updated systematic review and meta-analysis. J Med Life Borhan W, Assinnari A, Bakhsh A, Alnazari M, Rajih E. PMID: 41958510 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 186954

Page 1 of 9348



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy